Yeo and colleagues explained that with rising obesity in the U.S., the increasing prevalence of GLP-1 receptor agonists prescribed for obesity may contribute to drug shortages. Further, drug shortages may exacerbate the existing nationwide racial and ethnic disparities in GLP-1 receptor agonist prescriptions, they wrote, adding that the results suggest a call for strategies to address the growing demand and ensure equitable access to the drugs.
10.1210/endocr/bqz046 102 SchlaepferI
Semaglutide has proven cardiovascular benefit, 7+ years of safety data, and global availability
Yes, eggs are among nutrient-dense foods that become more important as patients who take anti-obesity medications eat less, the Obesity study authors note
Employer Exclusions of Anti-Obesity Medications in Commercial Health Plans
Additionally, quercetin has demonstrated protective effects against Cis-induced AKI in vivo (Snchez-Gonzlez et al., 2017) and has been shown to safeguard human renal proximal tubular cells against the toxicity of radiocontrast media in vitro (Lu et al., 2018) illustrated that quercetin diminishes kidney injury by modulating the polarization of M1/M2 macrophages, thereby providing evidence that quercetins improvement of kidney inflammation and injury may be linked to macrophage function regulation
